S1 for NGIO all well and good. But the value behin
Post# of 36537
(Total Views: 319)
Posted On: 07/02/2020 8:59:59 AM
S1 for NGIO all well and good. But the value behind it seems to see the market differently, although the Oasis financing has now become more public.
MSO centers, pharmacy purchases and what Generex has not been or should be. The acquisitions, which were also plentiful, were still not paid and do not contribute to sales. But you should, even without additional funds.
Hoping for funding after such a long period of time is in vain in my opinion. Maybe Joe, like the China business, will still leave us in the dark after the big announcement.
Wouldn't surprise me.
After the dividend payment, we can immediately get our other areas up and running ... it just depends on the payment ...
In summary: far too many purchases + far too many lawsuits + no relevant sales + dreaming of the CEO = 50 million goodwill
MSO centers, pharmacy purchases and what Generex has not been or should be. The acquisitions, which were also plentiful, were still not paid and do not contribute to sales. But you should, even without additional funds.
Hoping for funding after such a long period of time is in vain in my opinion. Maybe Joe, like the China business, will still leave us in the dark after the big announcement.
Wouldn't surprise me.
After the dividend payment, we can immediately get our other areas up and running ... it just depends on the payment ...
In summary: far too many purchases + far too many lawsuits + no relevant sales + dreaming of the CEO = 50 million goodwill
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼